Detalhe da pesquisa
1.
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230.
Cancers (Basel)
; 15(9)2023 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174130
2.
Sulfonimidamides by Sequential Mechanochemical Chlorinations and Aminations of Sulfinamides.
Org Lett
; 24(23): 4109-4113, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658444
3.
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study.
Cancers (Basel)
; 14(1)2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008392
4.
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer.
EJNMMI Res
; 12(1): 60, 2022 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104637
5.
Syntheses of Trifluoroethylated N-Heterocycles from Vinyl Azides and Togni's Reagent Involving 1,n-Hydrogen-Atom Transfer Reactions.
Org Lett
; 22(12): 4766-4770, 2020 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496070
6.
Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer.
EJNMMI Res
; 13(1): 12, 2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763205
7.
Organic Dye-Catalyzed Atom Transfer Radical Addition-Elimination (ATRE) Reaction for the Synthesis of Perfluoroalkylated Alkenes.
Org Lett
; 19(16): 4295-4298, 2017 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28766948